[Therapeutic considerations on kinetoses].
D000054:Acceleration / Q000009:adverse effects; D000337:Aerospace Medicine; D000661:Amphetamine / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy* / Q000209:etiology; D012601:Scopolamine / Q000627:therapeutic use*; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*
D001463:Barbiturates; D006634:Histamine H1 Antagonists; D046948:Secologanin Tryptamine Alkaloids; D013566:Sympathomimetics; D000661:Amphetamine; D012601:Scopolamine
Considerazioni terapeutiche sulle chinetosi.